Crystal's Coder Hub🧬 ICD-10 CM N18.32 — Chronic Kidney Disease, Stage 3b
Billable Code Confirmed
ICD-10-CM N18.32 is a valid, billable 5-character ICD-10-CM code for FY2026. Characters 1-3 (N18) define the category (Chronic kidney disease); character 4 (.3) defines the subcategory (Stage 3, moderate); and character 5 (2) specifies stage 3b, distinguishing it from stage 3a (N18.31) and unspecified stage 3 (N18.30). No additional characters are required — this is a fully specified, terminal code.
Non-Billable Parent Codes — Never Submit These
- ❌
N18— 3-character header — no stage, etiology, or severity specificity- ❌
N18.3— 4-character header — specifies “moderate” but does not differentiate 3a vs. 3bAlways submit N18.32 (all 5 characters) when CKD Stage 3b is documented with an eGFR between 30-44 mL/min/1.73 m² or when the provider explicitly documents “Stage 3b” CKD.
Clinical Context: Stage 3b vs. 3a — A Critical Distinction for HCC and DRG Capture
ICD-10-CM N18.32 captures the more severe half of Stage 3 CKD. Stage 3a (N18.31) reflects eGFR 45-59; Stage 3b (N18.32) reflects eGFR 30-44 — a meaningful prognostic difference. Under CMS-HCC v28, N18.32 maps to HCC 328, while N18.31 and the unspecified N18.30 map to HCC 329. Selecting the correct sub-stage is both a compliance requirement and a risk adjustment accuracy issue.
Code Classification
ICD-10-CM Diagnosis Code — wRVU, assistant payable, and global period fields are not applicable to this diagnosis code. For associated procedures and services, refer to the CPT Procedural Crosswalk and ICD-10-PCS Crosswalk sections below.
🔍 Code Description
ICD-10-CM N18.32 classifies Chronic kidney disease, stage 3b — a progressive, irreversible reduction in kidney function defined by an estimated glomerular filtration rate (eGFR) of 30-44 mL/min/1.73 m², persisting for three months or more and confirmed on repeat testing to exclude acute kidney injury. Stage 3b represents moderate-to-severe kidney function loss, with the kidneys operating at roughly 30-44% of normal filtration capacity.
At this stage, the kidneys’ reduced ability to filter waste and regulate fluid and electrolyte balance begins to manifest clinically: patients often develop anemia (due to decreased erythropoietin production), mineral and bone disorder (from impaired phosphate excretion and vitamin D activation), and accelerating cardiovascular risk. The underlying etiology — most commonly diabetic nephropathy (requiring “code first” linkage to E08.22-E13.22) or hypertensive chronic kidney disease (I12.-, I13.-) — must be coded first per ICD-10-CM sequencing instructions.
🌳 Code Tree / Hierarchy
N18 Chronic kidney disease (CKD) ❌ Non-billable
│
├── N18.1 CKD, Stage 1 ✅ Billable
├── N18.2 CKD, Stage 2 (mild) ✅ Billable
│
├── N18.3 CKD, Stage 3 (moderate) ❌ Non-billable
│ │
│ ├── N18.30 CKD, Stage 3, unspecified ✅ Billable
│ ├── N18.31 CKD, Stage 3a ✅ Billable
│ └── N18.32 CKD, Stage 3b ◀ THIS CODE ✅ Billable
│
├── N18.4 CKD, Stage 4 (severe) ✅ Billable
├── N18.5 CKD, Stage 5 ✅ Billable
└── N18.6 End stage renal disease (ESRD) ✅ Billable
Specificity Drives HCC Tier — Don't Default to Unspecified
Submitting N18.30 (Stage 3 unspecified) maps to HCC 329 under v28; submitting N18.32 maps to the more severe HCC 328 — same RAF coefficient of 0.127 currently, but correct mapping ensures audit defensibility and accurately reflects documented disease burden. Always query the provider for sub-stage specificity when the eGFR value is documented in the chart.
✅ Includes
The following clinical terms and scenarios map to N18.32 when documented:
- Chronic kidney disease, Stage 3b (explicit provider documentation)
- Chronic renal insufficiency with eGFR 30-44 mL/min/1.73 m² (confirmed ≥ 3 months)
- Moderate-to-severe CKD, GFR class G3b per KDIGO staging
- CKD with GFR 30-44 in the setting of diabetic nephropathy (code E11.22 first) or hypertensive CKD (code I12.9 or I13.- first)
❌ Excludes
Excludes 1 — Cannot Be Coded Simultaneously with N18.32
| Code | Description | Note |
|---|---|---|
| N18.6 | End stage renal disease | ESRD and a specific CKD stage are mutually exclusive — if dialysis is documented, code N18.6, not a stage-specific code |
| N19 | Unspecified kidney failure | Cannot code both CKD (N18.x) and unspecified kidney failure (N19) simultaneously — N19 is used only when CKD vs. AKI is not specified |
Excludes 1 Violation Risk
The most common violation occurs when a coder assigns both N18.32 and N18.6 for a patient on dialysis who also has a documented CKD stage. If ESRD (N18.6) is documented, it supersedes the stage-specific code — submit N18.6 only. Similarly, never submit N18.32 alongside N19; if the provider documents chronic kidney disease with a stage, use the appropriate N18 code.
Excludes 2 — May Be Coded in Addition if Separately Present
| Code | Description | Note |
|---|---|---|
| N17.x | Acute kidney failure/injury (AKI) | AKI superimposed on CKD 3b may be coded simultaneously — document “acute on chronic kidney disease” to justify both; AKI code sequences first |
📋 Clinical Overview
Stage 3 CKD Sub-Stage Differentiation
The ICD-10-CM split of Stage 3 into 3a and 3b mirrors KDIGO (Kidney Disease: Improving Global Outcomes) staging, which recognizes that patients with eGFR 30-44 have markedly higher risks of CKD progression, cardiovascular events, and hospitalizations compared to those with eGFR 45-59.
| Feature | N18.32 — Stage 3b | N18.31 — Stage 3a | N18.4 — Stage 4 |
|---|---|---|---|
| eGFR Range | 30-44 mL/min/1.73 m² | 45-59 mL/min/1.73 m² | 15-29 mL/min/1.73 m² |
| KDIGO GFR Class | G3b | G3a | G4 |
| CMS-HCC v28 | HCC 328 | HCC 329 | HCC 327 |
| RAF Coefficient (v28) | ~0.127 | ~0.127 | ~0.514 |
| Clinical Severity | Moderate to Severe | Moderate | Severe |
| Nephrology Referral | Strongly recommended | Recommended | Mandatory |
| Anemia of CKD | Common | Early presentation | Expected |
| Mineral/Bone Disorder | Emerging | Early monitoring | Active management |
CDI Query Trigger — CKD Stage Specificity
When the chart contains an eGFR lab value of 30-44 but the provider documents only “CKD” or “CKD Stage 3” without specifying 3a vs. 3b, a CDI query is warranted. The query should ask: “Based on the documented eGFR of [value], does the patient have Stage 3a or Stage 3b CKD?” This drives the N18.31 vs. N18.32 distinction and directly impacts HCC mapping accuracy.
Manifestations & Symptom Burden
Common manifestations and complications associated with CKD Stage 3b that should be coded when documented:
- Anemia of chronic kidney disease: Reduced erythropoietin production leads to normocytic, normochromic anemia; code separately with D63.1
- Mineral and bone disorder in CKD: Impaired phosphate excretion, reduced vitamin D3 activation → secondary hyperparathyroidism; code with N25.81
- Hypertension: Presumed causally linked to CKD — code with I12.9 (hypertensive CKD) per ICD-10-CM convention; do not code separately with I10 + N18.32
- Hyperkalemia: Reduced renal potassium excretion; code separately with E87.5 when documented
- Metabolic acidosis: Reduced acid excretion capacity; code separately with E87.2 when documented
- Fluid overload / edema: Impaired sodium and water excretion; code separately when documented
Coding Manifestations
Always code documented manifestations to fully capture patient complexity and support medical necessity for nephrology services. Examples include:
- D63.1 — Anemia in chronic kidney disease
- N25.81 — Secondary hyperparathyroidism of renal origin
- E87.5 — Hyperkalemia
💰 HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (Fully operative PY2026) |
| HCC Assignment | ✅ Mapped — HCC 328 |
| HCC Category | HCC 328 — Chronic Kidney Disease, Stage 3b |
| RAF Coefficient | ~0.127 (community, nondual, aged enrollees) |
N18.32 maps directly to HCC 328 under CMS-HCC v28 and contributes to the RAF score for Medicare Advantage risk adjustment.
Capture Annually
HCC 328 requires annual recapture — if N18.32 is not submitted each calendar year for a Medicare Advantage patient, the HCC drops from the risk score and the plan faces a RAF shortfall that does not reflect the patient’s true chronic disease burden. CKD Stage 3b is a chronic, progressive condition that will not resolve; annual documentation and coding ensures payer risk scores align with actual resource utilization. Note that N18.32 maps to HCC 328 (Stage 3b-specific), distinct from HCC 329 (which captures N18.30 unspecified and N18.31 Stage 3a) — specificity matters for audit defensibility even when the RAF coefficient is currently equivalent.
🏥 MS-DRG Assignment
MDC 11 — Diseases and Disorders of the Kidney and Urinary Tract
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 682 | Renal Failure with MCC | ~1.48-1.50 |
| DRG 683 | Renal Failure with CC | ~0.89 |
| DRG 684 | Renal Failure without CC/MCC | ~0.60 |
Approximate. Verify against IPPS FY2026 Final Rule tables (MS-DRG v43.1, effective 10/1/2025).
Sequencing and Complications
When N18.32 is the principal diagnosis, the encounter groups to DRG 682/683/684 based on the presence of MCCs or CCs among secondary diagnoses. When N18.32 is a secondary diagnosis, it functions as a CC — elevating the DRG grouping from the “without CC/MCC” tier to the “with CC” tier across many MDCs. N18.32 does not qualify as an MCC. Common MCC-level comorbidities that drive DRG 682 include sepsis, respiratory failure, and hypovolemic shock. Coders should ensure all CKD-related manifestations (anemia, hyperkalemia, metabolic acidosis) are coded when documented, as these may serve as additional CCs.
🔗 Related ICD-10-CM Codes
Stage Progression Within N18
| Code | Description |
|---|---|
| N18.30 | CKD, Stage 3, unspecified |
| N18.31 | CKD, Stage 3a (eGFR 45-59) |
| N18.32 | CKD, Stage 3b (eGFR 30-44) ← This Code |
| N18.4 | CKD, Stage 4, severe (eGFR 15-29) |
| N18.5 | CKD, Stage 5 (eGFR < 15) |
| N18.6 | End stage renal disease (ESRD) |
Etiology-Linked Combination Codes (Code First)
| Code | Description |
|---|---|
| I12.9 | Hypertensive chronic kidney disease with stage 1-4 CKD or unspecified CKD — code first, then N18.32 |
| I13.10 | Hypertensive heart and CKD without heart failure, with stage 1-4 CKD — code first, then N18.32 |
| E11.22 | Type 2 DM with diabetic CKD — code first, then N18.32 |
| E10.22 | Type 1 DM with diabetic CKD — code first, then N18.32 |
🛠️ Commonly Associated CPT Codes (Nephrology / Inpatient)
Inpatient and Outpatient Nephrology Setting Context
These CPT codes are typically associated with the evaluation and management of CKD Stage 3b in both the inpatient facility and outpatient nephrology settings. In the profee setting, Modifier -26 applies when the professional component of diagnostic imaging or renal biopsy interpretation is billed separately from the technical component.
| CPT Code | Description | Profee Coding Notes (Modifier 26) |
|---|---|---|
| 99213-99215 | Office/outpatient E/M, established patient | Use appropriate MDM-based level; no modifier needed for standalone E/M |
| 99232-99233 | Subsequent hospital inpatient E/M | Bill for nephrology consult/follow-up during inpatient stay for CKD management |
| 50200 | Renal biopsy, percutaneous | Append Modifier -26 for profee interpretation only; requires ultrasound guidance |
| 76775 | Ultrasound, retroperitoneal (renal) | Append Modifier -26 for professional component only in profee billing |
| 90935 | Hemodialysis procedure with single evaluation | Used if CKD 3b progresses acutely or ESRD develops; requires N18.6 for ESRD |
| 36819 | Arteriovenous anastomosis, open (AV fistula creation) | Placed in anticipation of ESRD; report with Z48.89 or appropriate surgical follow-up code |
NCCI Bundling Considerations
- Renal ultrasound (76775) billed on the same day as an E/M (99213-99215) requires that the E/M reflect a separately identifiable service; Modifier -25 on the E/M establishes this distinction.
- Renal biopsy (50200) and ultrasound guidance (76942) are a standard pair; 76942 is bundled into 50200 when performed by the same provider — unbundling requires documentation of a distinct, separate imaging indication.
🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)
When N18.32 is an inpatient diagnosis, these PCS codes are relevant for associated inpatient procedures.
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 5 (Extracorporeal or Systemic Therapies) | A (Physiological Systems) | 1D (Urinary Filtration — Hemodialysis) | Intermittent hemodialysis for acute decompensation or AKI-on-CKD: 5A1D70Z. Note: N18.32 does not itself indicate dialysis; this applies if acute deterioration warrants inpatient HD. |
| 0 (Medical and Surgical) | T (Urinary System) | B (Excision — Renal Biopsy) | Percutaneous renal biopsy to establish etiology of CKD: 0TB03ZX (Right kidney, percutaneous, diagnostic). |
| 3 (Administration) | E (Physiological Systems) | 1 (Introduction — Peritoneal Dialysis Solution) | Peritoneal dialysis access/instillation if transitioning to PD: 3E1M39Z. |
💊 Coding Scenarios and Examples
Scenario 1 — Inpatient: CKD 3b as Principal Diagnosis with Hyperkalemia and Metabolic Acidosis
Clinical Vignette: A 68-year-old male with a history of Type 2 diabetes mellitus and hypertension is admitted for worsening fatigue, nausea, and decreased urine output. Labs reveal eGFR of 32 mL/min/1.73 m², potassium 6.1 mEq/L, and bicarbonate of 17 mEq/L. The provider documents “CKD Stage 3b secondary to diabetic nephropathy” as the principal reason for admission. The patient is managed medically and stabilized without dialysis.
Principal Diagnosis:
- E11.22 — Type 2 DM with diabetic chronic kidney disease (Code first per ICD-10-CM convention)
Secondary Diagnoses:
- N18.32 — CKD, Stage 3b (Required “use additional code” per E11.22 instructional note)
- E87.5 — Hyperkalemia (Separately documented and managed)
- E87.2 — Acidosis / Metabolic acidosis (Separately documented)
- I10 — Essential hypertension (Note: if hypertensive CKD linkage documented, use I12.9 instead of I10 + N18.32)
MS-DRG Assignment: With E87.5 (Hyperkalemia) serving as a CC, this case groups to DRG 683 (Renal Failure with CC), improving reimbursement over DRG 684.
Scenario 2 — Inpatient: CKD 3b as Secondary Diagnosis with Sepsis as Principal
Clinical Vignette: A 74-year-old female with known CKD Stage 3b (last eGFR 38) and hypertension is admitted with a urinary tract infection that has progressed to urosepsis. Blood cultures are positive for E. coli. The attending documents “sepsis due to urinary tract infection” as the reason for admission. CKD 3b is listed as a comorbidity. The patient requires IV antibiotics and monitoring for fluid balance given her reduced kidney function.
Principal Diagnosis:
- A41.51 — Sepsis due to Escherichia coli
Secondary Diagnoses:
- N39.0 — Urinary tract infection, site not specified (Source/etiology of sepsis)
- N18.32 — CKD, Stage 3b (Active comorbidity — functions as CC, elevating DRG tier)
- I12.9 — Hypertensive CKD with stage 1-4 CKD (Code first if hypertension is causally linked)
MS-DRG Assignment: N18.32 as a CC shifts the sepsis DRG from MDC 18 “without CC/MCC” tier to “with CC” tier, directly impacting relative weight and reimbursement. Confirm that both the sepsis code and CKD are explicitly documented and clinically supported.
Scenario 3 — CDI Query: Undifferentiated “Stage 3 CKD” Documentation
Clinical Vignette: A 71-year-old male is discharged after a 3-day inpatient admission for hypertensive urgency. The discharge summary notes “chronic kidney disease, Stage 3” and the most recent eGFR on admission is documented as 36 mL/min/1.73 m² in the labs. The coder cannot determine whether to assign N18.30, N18.31, or N18.32 based on the documentation alone.
Action / Outcome: The documentation “Stage 3 CKD” without sub-stage designation forces assignment of N18.30 (unspecified Stage 3), which maps to HCC 329 and may underrepresent severity. A CDI query should be submitted asking the provider to confirm the sub-stage based on the eGFR of 36, which clinically falls within the Stage 3b range (30-44).
Query Response: Provider updates documentation to confirm: “CKD Stage 3b, eGFR 36 mL/min/1.73 m² consistent with Stage 3b per KDIGO classification.”
Corrected ICD-10-CM Coding:
- N18.32 — CKD, Stage 3b (Specific, auditable, maps to HCC 328)
- I12.9 — Hypertensive CKD (Sequenced first; assumed causal linkage per ICD-10-CM convention)
⚠️ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| ❌ | Defaulting to N18.30 (Unspecified Stage 3). When the eGFR value is documented in the chart and falls clearly within 30-44, submitting N18.30 is inaccurate and misses the opportunity to map to HCC 328. Query the provider for sub-stage confirmation. |
| ❌ | Coding I10 + N18.32 simultaneously when hypertension is the cause. ICD-10-CM assumes a causal relationship between hypertension and CKD. When both are documented, you must use I12.9 (or I13.x if heart failure is also present) as the “code first” diagnosis — not I10 separately. |
| ❌ | Failing to apply the “code first” instruction. When CKD 3b is due to diabetic nephropathy (E11.22) or hypertensive CKD (I12.9), those etiology codes must be sequenced first. Submitting N18.32 as the sole code is a coding error. |
| ✅ | Query for stage specificity every time. The eGFR is almost always in the chart even if the provider only writes “CKD Stage 3.” A sub-stage query is clinically straightforward and has direct HCC and DRG implications. |
| ✅ | Code all documented manifestations. Anemia (D63.1), secondary hyperparathyroidism (N25.81), hyperkalemia (E87.5), and metabolic acidosis (E87.2) are separately codeable and add CC weight in the inpatient setting. |
| ✅ | Annual HCC recapture for MA patients. CKD Stage 3b (HCC 328) must be documented and coded every calendar year for Medicare Advantage patients to maintain the RAF contribution. Educate providers to address and re-document all chronic conditions at each visit. |